# Electronic Medical Records and Genomics (eMERGE) Phase III

> **NCT03394859** · — · COMPLETED · sponsor: **Vanderbilt University Medical Center** · enrollment: 25380 (actual)

## Conditions studied

- Cardiac Disease
- Cancer
- Hypercholesterolemia
- Diabetes
- Kidney Diseases
- Neuromuscular Diseases

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03394859
- **Lead sponsor:** Vanderbilt University Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09-01
- **Primary completion:** 2020-04-01
- **Final completion:** 2020-04-01
- **Target enrollment:** 25380 (ACTUAL)
- **Last updated:** 2020-05-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03394859

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03394859, "Electronic Medical Records and Genomics (eMERGE) Phase III". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT03394859. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*